Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 731-740     DOI: 10.31083/j.rcm2203080
Special Issue: Contemporary Management of Special Subsets of Acute Coronary Syndromes Patients
Review Previous articles | Next articles
Current management and prognosis of patients with recurrent myocardial infarction
Leonardo De Luca1, *(), Luca Paolucci2, Annunziata Nusca2, Rita Lucia Putini1, Fabio Mangiacapra2, Enrico Natale1, Gian Paolo Ussia2, Furio Colivicchi3, Francesco Grigioni2, Francesco Musumeci4, Domenico Gabrielli1
1Department of Cardiosciences, Division of Cardiology, A. O. San Camillo-Forlanini, 00152 Rome, Italy
2Department of Medicine, Unit of Cardiovascular Science, Campus Bio-Medico University, 00128 Rome, Italy
3Division of Cardiology, San Filippo Neri Hospital, 00186 Rome, Italy
4Department of Cardiosciences, Cardiac Surgery Unit and Heart Transplantation Center, A. O. San Camillo-Forlanini, 00152 Rome, Italy
Download:  PDF(131KB)  ( 220 ) Full text   ( 23 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Recurrent myocardial infarction (re-MI) is a common event following acute coronary syndrome (ACS), especially during the first year. According to epidemiological studies, patients who experience re-MI are at higher risk of all-cause cardiovascular events and mortality. The cornerstones of re-MI prevention include complete functional coronary revascularization, effective dual antiplatelet therapy and secondary prevention strategies. Notwithstanding this, some controversy still exists on the definition and management of re-MI, and no dedicated studies have been designed or conducted so far in this setting. We here provide an overview of epidemiological and prognostic data on ACS patients experiencing re-MI, along with current available treatment and preventive options.
Key words:  Recurrent myocardial infarction      Acute coronary syndrome      Secondary prevention      Dual antiplatelet therapy      Percutaneous coronary intervention     
Submitted:  30 May 2021      Revised:  29 July 2021      Accepted:  04 August 2021      Published:  24 September 2021     
*Corresponding Author(s):  Leonardo De Luca     E-mail:  leo.deluca@libero.it

Cite this article: 

Leonardo De Luca, Luca Paolucci, Annunziata Nusca, Rita Lucia Putini, Fabio Mangiacapra, Enrico Natale, Gian Paolo Ussia, Furio Colivicchi, Francesco Grigioni, Francesco Musumeci, Domenico Gabrielli. Current management and prognosis of patients with recurrent myocardial infarction. Reviews in Cardiovascular Medicine, 2021, 22(3): 731-740.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm2203080     OR     https://rcm.imrpress.com/EN/Y2021/V22/I3/731

[1] Călin Pop, Diana Țînț, Antoniu Petris. Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 659-675.
[2] César Jiménez-Méndez, Pablo Díez-Villanueva, Fernando Alfonso. Non-ST segment elevation myocardial infarction in the elderly[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 779-786.
[3] Yun-Tao Feng, Xiang-Fei Feng. Sudden cardiac death in patients with myocardial infarction: 1.5 primary prevention[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 807-816.
[4] Eduardo Matos Vilela, Ricardo Ladeiras-Lopes, Ana João, Susana Torres, José Ribeiro, Lilibeth Campos, Fátima Miranda, José Pedro Nunes, Madalena Teixeira, Ricardo Fontes-Carvalho. Cardiac rehabilitation in elderly myocardial infarction survivors: focus on circulatory power[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 903-910.
[5] Dan Ke, Xi He, Chaogui Lin, Lianglong Chen. Comparison of standard versus modified stenting technique for treatment of tapered coronary artery lesions[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 931-938.
[6] Xiao-Fei Wang, Meng-Cheng Xu, Cheng-Yu Mao, En-Zhou, Qing He, Xing-Qian Qu, Yu-Qi Fan, Chang-Qian Wang, Jun-Feng Zhang. Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1009-1017.
[7] Marco Schiavone, Federica Sabato, Cecilia Gobbi, Marialessia Denora, Lucrezia Zanchi, Alessio Gasperetti, Giovanni B. Forleo. Atrioventricular and intraventricular blocks in the setting of acute coronary syndromes: a narrative review[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 287-294.
[8] Nicholas C. Sanderson, William A. E. Parker, Robert F. Storey. Ticagrelor: clinical development and future potential[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 373-394.
[9] Si-Yi Li, Ming-Gang Zhou, Tao Ye, Lian-Chao Cheng, Feng Zhu, Cai-Yan Cui, Yu-Mei Zhang, Lin Cai. Frequency of ST-segment elevation myocardial infarction, non-ST-segment myocardial infarction, and unstable angina: results from a Southwest Chinese Registry[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 239-245.
[10] Yu-Hao Zhao, Lei Zhao, Xin-Chun Yang, Pan Wang. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 159-165.
[11] Farah Yasmin, Syed Muhammad Shujauddin, Aisha Naeem, Adina Jabeen, Syed Muhammad Ismail Shah, Rohan Kumar Ochani, Osama Mohiuddin, Anosh Aslam Khan, Sumeen Jalees, Aminah Abdul Razzack, Shiza Salman, Shuja Abdul Karim Khan, Ahmad Mustafa, Hassan Mehmood Lak. Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 83-95.
[12] Yao-Yao Han, Zheng-Xiang Li, Rong Duan. Efficacy and safety of proton pump inhibitors combined with clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 167-174.
[13] Eric Bruckert, Gaelle Desamericq, Artak Khachatryan, Patrick Ngo, Gaelle Gusto, Francesc Sorio-Vilela. Patient characteristics, treatment patterns, and adherence to lipid-lowering therapies following an acute coronary syndrome[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 643-650.
[14] Gayatri Setia, Jeffrey Tyler, Alan Kwan, Josh Faguet, Shilpa Sharma, Siddharth Singh, Babak Azarbal, Rose Tompkins, Dinora Chinchilla, Sara Ghandehari. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 289-295.
[15] Federico Ronco, Giuseppe Tarantini, Peter A. McCullough. Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 9-23.
No Suggested Reading articles found!